Skip to content
Lawsuit Help Desk

Lawsuit News Center

CAR T-Cell Therapy Revolution: Tracing Penn Medicine's Pioneering Role and Breakthroughs in Modern Cancer Treatment

CAR T-Cell Therapy Revolution: Tracing Penn Medicine’s Pioneering Role and Breakthroughs in Modern Cancer Treatment

Penn Medicine has pioneered the development of CAR T-cell therapy in oncology, using the patient's immune system to fight cancer. This led to the approval of over 20 cancer drugs and techniques in the last five years, including drugs like Olaparib and Pafolacianine. This innovative approach contributed to a 33% decrease in U.S. cancer mortality since 1991. Furthermore, preliminary research suggests CAR T-cell therapy might also be effective in treating autoimmune diseases like lupus. Yet, as we laud these advancements, we must also evaluate their ethical implications and ensure equal access. The true revolution lies in both scientific innovation and accessibility.

Full article here: https://ipllfirm.com/all-insights/news-and-articles/car-t-cell-therapy-revolution-tracing-penn-medicines-pioneering-role-and-breakthroughs-in-modern-cancer-treatment/